Scandion Oncology (SCOL)

Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes for Scandion Oncology

Right Now

+/-: 8.2
%: 14,14%
Latest: 66.2
High: 66.8
Low: 58.6
Volume: 201 122
Turnover (SEK): 12 229 173
Value (MSEK): 1 261,3

Board

CEO

Nils Brünner

Chairman Of The Board

Peter Høngaard

Board

Annie Rasmussen
Bo Hansen
Carl Borrebäck
Christian Vinding Thomsen
Jørgen Bardenfleth
Thomas Feldthus

Articles of association

News

2020-08-01 13:14:46 Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 10% of the total share amount
2020-07-31 08:42:07 Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy in the first cohort of patients with chemo-resistant metastatic colorectal cancer
2020-07-11 10:01:40 Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal "Basic & Clinical Pharmacology & Toxocology".
2020-07-03 14:24:28 Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology
2020-06-30 18:27:29 Scandion Oncology co-founders extend lock-up period

News agencies

2020-08-06 11:25:21 Ritzau: BioStock: Strong first half of 2020 for Scandion Oncology
2020-08-06 11:19:19 Ritzau: BioStock: Starkt första halvår av 2020 för Scandion Oncology
2020-08-05 11:13:04 Ritzau: BioStock: New promising data from Scandion Oncology's cancer study
2020-08-05 11:08:18 Ritzau: BioStock: Nya lovande data i Scandion Oncologys cancerstudie
2020-08-03 15:22:19 Finwire: Lovande resultat från SCO-101, inga tecken på toxicitet - Scandion Oncology-vd

Analysis

2018-10-09 SvD Börsplus: Svår att motstå?

Videos

Largest Owners

Name	Capital %	Votes %	Date
Saniona AB	9,99	9,99	2020-07-31
Jan Stenvang	7,30	7,30	2020-03-31
Avanza Pension	5,71	5,71	2020-03-31
Nils Brünner	5,65	5,65	2020-06-15
Nordnet Pensionsförsäkring	4,17	4,17	2020-03-31
Christian Tang Jespersen	2,75	2,75	2020-03-31
Göran Ofsén	1,97	1,97	2020-03-31
Jørgen Bardenfleth	1,85	1,85	2020-03-31
Cecél Kolz	1,84	1,84	2020-03-31
Kim Arvid Nielsen	1,57	1,57	2020-03-31

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Scandion Oncology

Quotes for Scandion Oncology

Right Now

Board

News

News agencies

Analysis

Videos

Scandion Oncology från Öresundsdagen 20 maj

Bolagspresentation 25/6

Scandion Oncology - Sedermeradagen i Malmö 2018

Scandion Oncology A/S - Company presentation

Largest Owners

Insider trading

Key Numbers

Upcoming reports

Annual reports, prospectus etc.

Technical analysis

SCOL- 2019-03-07

Technical analysis

SCOL- 2019-01-07